BeyondSpring (BYSI) Receives CRL from the FDA for Plinabulin NDA for Prevention of Chemotherapy-Induced Neutropenia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AZN
6. ROIV
7. AAPL
8. HOOD
9. QCOM
10. ACN

Go back to BeyondSpring (BYSI) Receives CRL from the FDA for Plinabulin NDA for Prevention of Chemotherapy-Induced Neutropenia
(NASDAQ: BYSI) Delayed: 0.62 --0 (-0%)
Previous Close $0.62    52 Week High $ 
Open $0.62    52 Week Low $ 
Day High $0.63    P/E N/A 
Day Low $0.60    EPS $ 
Volume 31,005